Genflow Biosciences Statistics

Total Valuation

LON:GENF has a market cap or net worth of GBP 9.13 million. The enterprise value is 8.85 million.

Market Cap	9.13M
Enterprise Value	8.85M

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

LON:GENF has 493.55 million shares outstanding. The number of shares has increased by 20.39% in one year.

Current Share Class	493.55M
Shares Outstanding	493.55M
Shares Change (YoY)	+20.39%
Shares Change (QoQ)	+9.53%
Owned by Insiders (%)	47.20%
Owned by Institutions (%)	36.83%
Float	254.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-30.13
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.92
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.15

Financial Position

The company has a current ratio of 0.61

Current Ratio	0.61
Quick Ratio	0.56
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -648.46% and return on invested capital (ROIC) is -405.29%.

Return on Equity (ROE)	-648.46%
Return on Assets (ROA)	-123.70%
Return on Invested Capital (ROIC)	-405.29%
Return on Capital Employed (ROCE)	594.25%
Weighted Average Cost of Capital (WACC)	16.56%
Revenue Per Employee	n/a
Profits Per Employee	-360,119
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.71% in the last 52 weeks. The beta is 2.24, so LON:GENF's price volatility has been higher than the market average.

Beta (5Y)	2.24
52-Week Price Change	+5.71%
50-Day Moving Average	1.91
200-Day Moving Average	1.42
Relative Strength Index (RSI)	46.37
Average Volume (20 Days)	3,316,692

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.80M
Pretax Income	-1.80M
Net Income	-1.80M
EBITDA	-1.80M
EBIT	-1.80M
Earnings Per Share (EPS)	-0.00

Full Income Statement

Balance Sheet

The company has 279,445 in cash and n/a in debt, giving a net cash position of 279,445 or 0.00 per share.

Cash & Cash Equivalents	279,445
Total Debt	n/a
Net Cash	279,445
Net Cash Per Share	0.00
Equity (Book Value)	-303,003
Book Value Per Share	-0.00
Working Capital	-304,531

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.72 million and capital expenditures 743, giving a free cash flow of -1.72 million.

Operating Cash Flow	-1.72M
Capital Expenditures	743
Free Cash Flow	-1.72M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:GENF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.39%
Shareholder Yield	-20.39%
Earnings Yield	-19.72%
FCF Yield	-18.83%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2